Viking Launches Two Phase 3 Trials for Oral Obesity Drug
Viking Therapeutics launched two late-stage trials of its experimental oral weight-loss treatment VK2735.
The development comes as Viking expands its obesity drugs pipeline t…
Viking Therapeutics launched two late-stage trials of its experimental oral weight-loss treatment VK2735.
The development comes as Viking expands its obesity drugs pipeline t…